Double Dividend Stocks submits: With what looks like a rocky summer ahead of us, you might be searching for dividend paying stocks in defensive sectors, such as healthcare. Investors have been favoring healthcare stocks so far in 2011, sending the sector up nearly 14% year-to-date. The problem for income investors, though, is that the healthcare [...]

by Cathy Zimmerman, Ligia Kiss, Mazeda Hossain Further information: Article source

Title: Kids Who Bully Often Get Poor SleepCategory: Health NewsCreated: 6/3/2011 10:06:00 AMLast Editorial Review: 6/3/2011 Further information: Article source

Background: A breast cancer screening programme (BCSP) was started in 21 districts in the Khanty-Mansiysky Autonomous Okrug—Ugra region from 7 February 2007.Methods: From the data on the numbers of subjects screened and the resulting diagnoses we calculated screening coverage rates and cancer detection rates and estimated the sensitivity of the screening tests. The State Cancer [...]

The government should accelerate the timetable for handing GPs commissioning responsibility in areas where consortia are ready, the NHS Alliance has said. Further information: Article source

Dr. COLLIN’s latest product, the CMF 100, is an ideal system for the production of medical fibres. This compact, modular line offers easy handling and is suitable for frequent material changes. The line speed up to 1,000m/min and the extremely low throughput of the working extruder allow the production of very thin yarns. These yarns [...]

A new paper released by Quanticate provides an overview of some of the ways in which Phase I packages can be tailored to the needs of the specific compound and conducted more efficiently using combination, flexible protocols. It outlines the considerations that need to be made at the planning stage, and how to make best [...]

(Research Australia) Formoterol, a new generation asthma medication, shows great promise for improving fat and protein metabolism, say Australian researchers, who have tested this effect in a small sample of men. The researchers presented their results on Saturday, June 4, 2011, at the Endocrine Society’s 93rd Annual Meeting in Boston. (Source: EurekAlert! – Medicine and [...]

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from OCEANS, a Phase III study evaluating Avastin® (bevacizumab) in combination with chemotherapy (gemcitabine and carboplatin) followed by the continued use of Avastin alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer. Women who received Avastin experienced a 52 [...]

Todd Johnson submits: Human Genome Sciences (HGSI) is finally coming to market with the full FDA approved medication. The company’s early years hype, and later years near-death stock experience, can all be viewed in perspective. Benlysta has been approved by the FDA, and HGSI will take the lupus-treatment drug to market with partner GlaxoSmithKline (GSK). [...]